GONUTS has been updated to MW1.31 Most things seem to be working but be sure to report problems.
PMID:11567069
Citation |
King, MA, Bradshaw, S, Chang, AH, Pintar, JE and Pasternak, GW (2001) Potentiation of opioid analgesia in dopamine2 receptor knock-out mice: evidence for a tonically active anti-opioid system. J. Neurosci. 21:7788-92 |
---|---|
Abstract |
Dopamine systems are intimately involved with opioid actions. Pharmacological studies suggest an important modulatory effect of dopamine and its receptors on opioid analgesia. We have now examined these interactions in a knock-out model in which the dopamine(2) (D(2)) receptor has been disrupted. Loss of D(2) receptors enhances, in a dose-dependent manner, the analgesic actions of the mu analgesic morphine, the kappa(1) agonist U50,488H and the kappa(3) analgesic naloxone benzoylhydrazone. The responses to the delta opioid analgesic [d-Pen(2),d-Pen(5)]enkephalin were unaffected in the knock-out animals. Loss of D(2) receptors also potentiated spinal orphanin FQ/nociceptin analgesia. Antisense studies using a probe targeting the D(2) receptor revealed results similar to those observed in the knock-out model. The modulatory actions of D(2) receptors were independent of final sigma receptor systems because the final sigma agonist (+)-pentazocine lowered opioid analgesia in all mice, including the D(2) knock-out group. Thus, dopamine D(2) receptors represent an additional, significant modulatory system that inhibits analgesic responses to mu and kappa opioids. |
Links | |
Keywords |
3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer/pharmacology; Analgesia; Analgesics, Opioid/pharmacology; Animals; Dopamine Antagonists/pharmacology; Dose-Response Relationship, Drug; Drug Synergism; Enkephalin, D-Penicillamine (2,5)-/pharmacology; Heterozygote; Mice; Mice, Knockout; Morphine/pharmacology; Naloxone/analogs & derivatives; Naloxone/pharmacology; Oligonucleotides, Antisense/pharmacology; Opioid Peptides/pharmacology; Pain Measurement/drug effects; Pentazocine/pharmacology; Receptors, Dopamine D2/antagonists & inhibitors; Receptors, Dopamine D2/deficiency; Receptors, Dopamine D2/genetics; Receptors, Opioid, delta/agonists; Receptors, Opioid, kappa/agonists; Receptors, Opioid, mu/agonists; Receptors, sigma/agonists; Sulpiride/pharmacology |
edit table |
Significance
Annotations
Gene product | Qualifier | GO ID | GO term name | Evidence Code | with/from | Aspect | Notes | Status |
---|---|---|---|---|---|---|---|---|
edit table |
See also
References
See Help:References for how to manage references in GONUTS.